Geoffrey M. Parker - Jun 13, 2022 Form 4 Insider Report for Better Therapeutics, Inc. (BTTX)

Role
Director
Signature
/s/ Mark Heinen, Attorney-in-Fact
Stock symbol
BTTX
Transactions as of
Jun 13, 2022
Transactions value $
$36,183
Form type
4
Date filed
6/14/2022, 04:25 PM
Previous filing
Jun 10, 2022
Next filing
Oct 24, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BTTX Common Stock Purchase $36.2K +25K +166.67% $1.45 40K Jun 13, 2022 Direct F1
holding BTTX Common Stock 53.3K Jun 13, 2022 By Parker Trust F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.40 to $1.47, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F2 These shares are owned directly by the Geoffrey M. Parker and Jill G. Parker Rev Trust dtd 1/27/00 (the "Parker Trust"), and indirectly by the Reporting Person and his spouse, Jill G. Parker, as trustees of the Parker Trust.